image
Healthcare - Biotechnology - NASDAQ - US
$ 0.7846
-7.47 %
$ 36.7 M
Market Cap
-0.88
P/E
CASH FLOW STATEMENT
-33.5 M OPERATING CASH FLOW
-18.43%
0 INVESTING CASH FLOW
0.00%
23.7 M FINANCING CASH FLOW
-28.70%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Reviva Pharmaceuticals Holdings, Inc.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)(30m)(30m)(35m)(35m)202020202021202120222022202320232024202420252025
Net Income -29.9 M
Depreciation & Amortization 0
Capital Expenditures 0
Stock-Based Compensation 1.63 M
Change in Working Capital -4.54 M
Others -7.55 M
Free Cash Flow -33.5 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Feb-2020 Feb-2019
OPERATING CASH FLOW
Net Income (29.9) (39.3) (24.3) (8.5) (3.8) (0.8) (1.7)
Depreciation & Amortization 0 0 0 0 591 645 17.7 K
Deferred Income Tax 0 0 0 0 0 0 0
Stock Based Compensation 1.6 3.4 0.2 0.1 0 0 21.1 K
Other Operating Activities (0.7) 0.2 0.2 (1.6) 2.4 6.41 K 28.2 K
Change in Working Capital (4.5) 7.3 5.0 (0.7) (2.3) 0.6 0.5
Cash From Operations (33.5) (28.3) (19.0) (10.7) (3.7) (0.2) (1.1)
INVESTING CASH FLOW
Capital Expenditures 0 0 0 0 0 0 0
Other Items 0 0 0 0 0 0 0
Cash From Investing Activities 0 0 0 0 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0
Total Debt Repaid 0.5 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 149 5.7 19 K 98.5 K 12.8 0 0.2
Cash From Financing Activities 23.7 33.2 7.8 31.6 12.8 100 K 0.2
CHANGE IN CASH
Net Change In Cash (9.9) 4.8 (11.2) 20.9 8.8 (0.1) 0.1
FREE CASH FLOW
Free Cash Flow (33.5) (28.3) (19.0) (10.7) (3.7) (0.2) (1.1)